GlobeNewswire

Oboya får en viktig order i USA

Dela

Oboya Horticulture Industries AB (publ) (”Oboya”) har genom sitt helägda dotterbolag Oboya Metal Qingdao Co. Ltd i Qingdao, Kina fått en order från befintlig kund i USA. Ordervärdet uppgår till ca 0,37 MUSD, motsvarande ca 3,59 MSEK.  

Ordern avser leverans av blomstervagnar och kommer att levereras från september och fram till oktober 2019. Ordervärdet uppgår till 0,37 MUSD, motsvarande ca 3,59 MSEK.  Den befintliga kunden är ett av de ledande logistik-, transport- och serviceföretagen inom odlingsindustrin i Nordamerika. Blomstervagnarna kommer att användas för såväl effektiv transport som för exponering av växter eller blommor i butik.

"Det är glädjande att det finns fortsatt efterfrågan på Oboyas produkter i USA, trots nuvarande handelskonflikt mellan Kina och USA. Vi kommer att fortsätta att etablera oss på marknaden och därigenom successivt öka våra marknadsandelar globalt på sikt”, säger Robert Wu, VD för Oboya Horticulture Industries AB.    

Erik Penser Bank AB är Oboyas Certified Adviser på Nasdaq First North. Tel: + 46 8-463 83 00
E-post: certifiedadviser@penser.se

För mer information, vänligen kontakta:

Robert Wu, VD Oboya Horticulture Industries AB (publ)

Tel: + 86 159 6983 5999
E-post: robert.wu@oboya.cc
Hemsida: www.oboya.se


Om Oboya Horticulture Industries AB

Oboya Horticulture har som mål att utvecklas till en världsledande totalleverantör inom dagliga förbrukningsvaror och logistikprodukter till odlingsindustrin samt konsumentprodukter för hemmaodling och inomhusmiljö. Produktion sker i fabriker i Kina, Vietnam, Polen och Kenya. Mer information om bolaget finns på www.oboya.se.

Bilaga

Om

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

HALF-YEAR RESULTS 2020: UNIBAIL-RODAMCO-WESTFIELD N.V.25.9.2020 20:00:00 CESTPress release

Amsterdam, September 25, 2020 Press Release HALF-YEAR RESULTS 2020: UNIBAIL-RODAMCO-WESTFIELD N.V. On September 25, 2020, Unibail-Rodamco-Westfield N.V. (“URW NV”) announced its 2020 half-year results and released its consolidated interim financial statements for the period ending June 30, 2020, which can be found on: https://www.urw-nv.com/en/investors/press-releases https://www.urw-nv.com/en/investors/press-releases and as an attachment to this press release. URW NV and its consolidated entities, together with Unibail-Rodamco-Westfield SE (“URW SE”) and its consolidated entities, form Unibail-Rodamco-Westfield (“URW”). URW SE consolidates URW NV and its controlled undertakings, and its 2020 half-year results represent a comprehensive overview of URW, and is available on: https://www.urw.com/en/investors/financial-information/financial-results https://www.urw.com/en/investors/financial-information/financial-results For further information, please contact: Investor Relations Media Rela

EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS  WITH  MODERATE  TO  SEVERE ACTIVE  RHEUMATHOID  ARTHRITIS25.9.2020 19:00:00 CESTPress release

-- Jyseleca® Demonstrated Durable Efficacy Combined with a Consistent Safety Profile in Rheumatoid Arthritis Through 52 Weeks in Phase 3 Clinical Development Program -- Foster City, Calif., & Mechelen, Belgium, September 25, 2020, 19.00 CET – Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the European Commission (EC) has granted marketing authorization for Jyseleca® (filgotinib 200 mg and 100 mg tablets), a once-daily, oral, JAK1 inhibitor for the treatment of adults with moderate to severe active rheumatoid arthritis (RA) who have responded inadequately to, or are intolerant to, one or more disease modifying anti-rheumatic drugs (DMARDs). Jyseleca may be used as monotherapy or in combination with methotrexate (MTX).1 RA is a chronic, progressive, systemic, inflammatory disease that can lead to significant and irreversible joint destruction, pain and functional impairment.2 Almost 3 million people in Europe are living with RA,3 many

Correction: CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS25.9.2020 17:10:39 CESTPress release

Sveriges Riksbank Bid procedure details Covered Bonds, 2020-10-01 Maturity dateLoanISIN codeCouponVolume, SEK million2023-09-20 5533 SE00104427311.25 %1,000 +/- 5002023-12-01 576 SE00100498411.00 %1,000 +/- 500 2023-06-011587SE00104413031.50 %1,000 +/- 5002023-12-20193SE00110896221.00 %1,000 +/- 5002023-12-202312SE00111164741.00 %300 +/- 1502023-09-20516SE00091903901.25 %600 +/- 2502023-06-21144SE00111674281.00 %600 +/- 250 Settlement date 2020-10-05 Bids have to be entered by 10.00 on OCT 1, 2020 Highest permitted bid volume: 1,000 SEK million in issue 5533 1,000 SEK million in issue 576 1,000 SEK million in issue 1587 1,000 SEK million in issue 193 300 SEK million in issue 2312 600 SEK million in issue 516 600 SEK million in issue 144 Maximum volume 5.5 billion SEK in total Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.15 (CEST) ON OCT 1, 2020. For more information, please con

Correction: CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS25.9.2020 17:10:00 CESTPress release

Sveriges Riksbank Bid procedure details Covered Bonds, 2020-10-01 Maturity dateLoanISIN codeCouponVolume, SEK million2023-09-20 5533 SE00104427311.25 %1,000 +/- 5002023-12-01 576 SE00100498411.00 %1,000 +/- 500 2023-06-011587SE00104413031.50 %1,000 +/- 5002023-12-20193SE00110896221.00 %1,000 +/- 5002023-12-202312SE00111164741.00 %300 +/- 1502023-09-20516SE00091903901.25 %600 +/- 2502023-06-21144SE00111674281.00 %600 +/- 250 Settlement date 2020-10-05 Bids have to be entered by 10.00 on OCT 1, 2020 Highest permitted bid volume: 1,000 SEK million in issue 5533 1,000 SEK million in issue 576 1,000 SEK million in issue 1587 1,000 SEK million in issue 193 300 SEK million in issue 2312 600 SEK million in issue 516 600 SEK million in issue 144 Maximum volume 5.5 billion SEK in total Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.15 (CEST) ON OCT 1, 2020. For more information, please con

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS25.9.2020 16:20:00 CESTPress release

Sveriges Riksbank Bid procedure details Covered Bonds, 2020-10-01 Maturity dateLoanISIN codeCouponVolume, SEK million2023-09-20 5533 SE00104427311.25 %1,000 +/- 5002023-12-01 578 SE00026959244.25 %1,000 +/- 500 2023-06-011587SE00104413031.50 %1,000 +/- 5002023-12-20193SE00110896221.00 %1,000 +/- 5002023-12-202312SE00111164741.00 %300 +/- 1502023-09-20516SE00091903901.25 %600 +/- 2502023-06-21144SE00111674281.00 %600 +/- 250 Settlement date 2020-10-05 Bids have to be entered by 10.00 on OCT 1, 2020 Highest permitted bid volume: 1,000 SEK million in issue 5533 1,000 SEK million in issue 578 1,000 SEK million in issue 1587 1,000 SEK million in issue 193 300 SEK million in issue 2312 600 SEK million in issue 516 600 SEK million in issue 144 Maximum volume 5.5 billion SEK in total Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.15 (CEST) ON OCT 1, 2020. For more information, please con

CONDITIONS FOR RIKSBANK BID PROCEDURE KOMMUNINVEST BONDS25.9.2020 16:20:00 CESTPress release

Sveriges Riksbank Bid procedure details Kommuninvest Bonds, 2020-09-29 Maturity dateLoanISIN codeCouponVolume, SEK million2022-06-012206SE00092694180.25 %1,100 +/- 2502023-11-132311SE00109482401.00 %1,100 +/- 2502025-05-12 2505 SE0011414010 1.00 % 1,100 +/- 250 2026-11-12 2611 SE0012569572 1.00 % 1,100 +/- 250 Maximum volume 4 310 million in total Settlement date 2020-10-01 Bids have to be entered by 11.00 on SEP 29, 2020 Highest permitted bid volume: 1 100 SEK million in issue 2206, 2311, 2505, and 2611. Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 11.15 (CEST) ON SEP 29, 2020 For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se